Comment contacter le centre
Centre de soins de santé
Fournir une haute qualité vérifiable
Proposer des soins de santé participatifs et personnalisés
Utiliser efficacement nos ressources
Participer à des réseaux professionnels durables dans tous les domaines
Le département d'ophtalmologie du Radboudumc est un centre tertiaire de premier plan pour diverses maladies oculaires et un expert de premier plan dans le traitement et la gestion des maladies de la rétine. Outre les soins cliniques quotidiens, nous recherchons les maladies de la rétine. Les principaux objectifs de nos recherches sont de mieux comprendre les bases moléculaires de ces maladies et de développer de nouveaux dispositifs de diagnostic et de nouvelles thérapies.
Le département de génétique humaine du Radboudumc mène des recherches révolutionnaires sur la relation entre les gènes et les maladies. Les soins aux patients (division de génétique clinique) et les diagnostics génétiques (division de diagnostic du génome) effectués au sein du département de génétique humaine sont hébergés par un centre officiel et réputé de génétique clinique.
Photo : .Koen
Contactez-Nous
Radboud university medical center, Nijmegen, Netherlands
équipe
Pr Carel HOYNG
Netherlands
Pr Frans Cremers
Netherlands
Essais cliniques
NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa
A Double-Masked, Randomized, Controlled, Multiple-Dose Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene (Sirius)
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)
Steroid Eye Drops Versus Placebo Eye Drops in Chronic Central Serous Chorioretinopathy Trial (PICS Trial)
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).
A double-masked, randomized, controlled, multiple-dose study to evaluate the efficacy, safety, tolerability and systemic exposure of QR-110 in Subjects with Leber’s Congenital Amaurosis (LCA) due to c.2991+1655A>G mutation (p.Cys998X) in the CEP290 gene (Illuminate).
Safety and Efficacy of Emixustat in Stargardt Disease.
Natural History of the Progression of Choroideremia Study NSR-CHM-OS1.
Rate of Progression in USH2A Related Retinal Degeneration
A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.
Half-dose photodynamic therapy versus eplerenone treatment in chronic centralserous chorioretinopathy.
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher
Natural history of the progression of X-linked retinitis pigmentosa.